| Validity and reliability of measurement instruments used in research CL Kimberlin, AG Winterstein American journal of health-system pharmacy 65 (23), 2276-2284, 2008 | 3542 | 2008 |
| Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection Committee on Infectious Diseases and Bronchiolitis Guidelines Committee Pediatrics 134 (2), e620-e638, 2014 | 898* | 2014 |
| Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care LA Thomsen, AG Winterstein, B S⊘ ndergaard, LS Haugb⊘ lle, ... Annals of Pharmacotherapy 41 (9), 1411-1426, 2007 | 560 | 2007 |
| Preventable drug-related hospital admissions AG Winterstein, BC Sauer, CD Hepler, C Poole Annals of Pharmacotherapy 36 (7-8), 1238-1248, 2002 | 463 | 2002 |
| Nature of preventable adverse drug events in hospitals: a literature review P Kanjanarat, AG Winterstein, TE Johns, RC Hatton, R Gonzalez-Rothi, ... American journal of health-system pharmacy 60 (17), 1750-1759, 2003 | 411 | 2003 |
| Drug—drug interactions in the elderly IK Björkman, J Fastbom, IK Schmidt, CB Bernsten, ... Annals of Pharmacotherapy 36 (11), 1675-1681, 2002 | 355 | 2002 |
| Potential adverse drug events and drug–drug interactions with medical and consumer cannabidiol (CBD) use JD Brown, AG Winterstein Journal of clinical medicine 8 (7), 989, 2019 | 332 | 2019 |
| Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ... JACC: Cardiovascular Interventions 11 (2), 181-191, 2018 | 289 | 2018 |
| Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries C Bernsten, I Björkman, M Caramona, G Crealey, B Frøkjær, ... Drugs & aging 18, 63-77, 2001 | 268 | 2001 |
| Identifying clinically significant preventable adverse drug events through a hospital’s database of adverse drug reaction reports AG Winterstein, RC Hatton, R Gonzalez-Rothi, TE Johns, R Segal American journal of health-system pharmacy 59 (18), 1742-1749, 2002 | 213 | 2002 |
| Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder AG Winterstein, T Gerhard, J Shuster, M Johnson, JM Zito, A Saidi Pediatrics 120 (6), e1494-e1501, 2007 | 177 | 2007 |
| Nature and causes of clinically significant medication errors in a tertiary care hospital AG Winterstein, TE Johns, EI Rosenberg, RC Hatton, R Gonzalez-Rothi, ... American Journal of Health-System Pharmacy 61 (18), 1908-1916, 2004 | 177 | 2004 |
| Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion DJ Guervil, AF Rosenberg, AG Winterstein, NS Harris, TE Johns, ... Annals of Pharmacotherapy 45 (7-8), 861-868, 2011 | 165 | 2011 |
| Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database AG Winterstein, T Gerhard, J Shuster, J Zito, M Johnson, H Liu, A Saidi Annals of Pharmacotherapy 42 (1), 24-31, 2008 | 153 | 2008 |
| Causes of hyperglycemia and hypoglycemia in adult inpatients WD Smith, AG Winterstein, T Johns, E Rosenberg, BC Sauer American Journal of Health-System Pharmacy 62 (7), 714-719, 2005 | 146 | 2005 |
| Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications C Hampp, TL Kauf, AS Saidi, AG Winterstein Archives of pediatrics & adolescent medicine 165 (6), 498-505, 2011 | 115 | 2011 |
| Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder M Olfson, C Huang, T Gerhard, AG Winterstein, S Crystal, PD Allison, ... Journal of the American Academy of Child & Adolescent Psychiatry 51 (2), 147-156, 2012 | 104 | 2012 |
| Ambulatory Care: Efficacy and Safety of Oral Phenylephrine: Systematic Review and Meta-Analysis RC Hatton, AG Winterstein, RP McKelvey, J Shuster, L Hendeles Annals of Pharmacotherapy 41 (3), 381-390, 2007 | 103 | 2007 |
| The IGNITE Pharmacogenetics Working Group: an opportunity for building evidence with pharmacogenetic implementation in a real‐world setting LH Cavallari, AL Beitelshees, KV Blake, LG Dressler, JD Duarte, A Elsey, ... Clinical and translational science 10 (3), 143, 2017 | 98 | 2017 |
| Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study AG Winterstein, T Gerhard, P Kubilis, A Saidi, S Linden, S Crystal, J Zito, ... Bmj 345, 2012 | 98 | 2012 |
Joshua D. BrownAssociate Professor, Center for Drug Evaluation & Safety, Pharmaceutical Outcomes & PolicyVerified email at ufl.edu
